Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
1,851
Views
6
CrossRef citations to date
0
Altmetric
Editorial

COVID-19: a challenge for oncology services

Bertrand Routya Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l’Université de Montréal (CHUM), Montréal, Canada;b Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, CanadaCorrespondence[email protected]
,
Lisa Derosac Gustave Roussy Cancer Campus (GRCC), Villejuif, France;d Institut National de la Santé et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée—Ligue Nationale Contre le Cancer, Villejuif, France;e Department of Medical Oncology, Gustave Roussy Cancer Campus (GRCC), Villejuif, France;f Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France
,
Laurence Zitvogelc Gustave Roussy Cancer Campus (GRCC), Villejuif, France;d Institut National de la Santé et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée—Ligue Nationale Contre le Cancer, Villejuif, France;e Department of Medical Oncology, Gustave Roussy Cancer Campus (GRCC), Villejuif, France;f Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France;g Faculté de Médecine Kremlin-Bicêtre, Université Paris Sud, Université Paris Saclay, France;h Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, ChinaORCID Iconhttps://orcid.org/0000-0003-1596-0998
ORCID Icon &
Guido Kroemerh Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China;i Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Campus, Villejuif, France;j Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France;k Aix-Marseille Université, MEPHI, IRD, IHU Méditerranée Infection, Marseille, France;l Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;m Karolinska Institute, Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, SwedenORCID Iconhttps://orcid.org/0000-0002-9334-4405
ORCID Icon
Article: 1760686 | Published online: 05 May 2020

References

  • Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3. doi:10.1038/s41586-020-2012-7.
  • Guan W, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, Liu L, Shan H, Lei C-L, Hui DSC, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;NEJMoa2002032. doi:10.1056/NEJMoa2002032.
  • Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3.
  • Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337. doi:10.1016/S1470-2045(20)30096-6.
  • Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020. doi:10.1001/jama.2020.4683.
  • Spicer J, Chamberlain C, Papa S. Provision of cancer care during the COVID-19 pandemic. Nat Rev Clin Oncol. 2020. doi:10.1038/s41571-020-0370-6.
  • Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A war on two fronts: cancer care in the time of COVID-19. Ann Intern Med. 2020. doi:10.7326/M20-1133.
  • Lala M, Li M, Sinha V, de Alwis D, Chartash E, Jain L. A six-weekly (Q6W) dosing schedule for pembrolizumab based on an exposure-response (E-R) evaluation using modeling and simulation. JCO. 2018;36(15_suppl):3062. doi:10.1200/JCO.2018.36.15_suppl.3062.
  • You B, Ravaud A, Canivet A, Ganem G, Giraud P, Guimbaud R, Kaluzinski L, Krakowski I, Mayeur D, Grellety T, et al. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol. 2020;S1470204520302047. doi:10.1016/S1470-2045(20)30204-7.
  • American Association for Cancer Research. Clinical research slows as COVID-19 surges. Cancer Discov. 2020. doi:10.1158/2159-8290.CD-NB2020-021.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.